Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:4:p2
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 4 (pt 2/22)
Character Range: 184083–187737

injection.
AMODIAQUINE.
AMOROLFINE except:
 (a) when included in Schedule 2; or
 (b) in preparations for the treatment of tinea pedis.
AMOXAPINE.
AMOXICILLIN.
AMPHOMYCIN.
AMPHOTERICIN B.
AMPICILLIN.
AMPRENAVIR.
AMRINONE.
AMSACRINE.
AMYL NITRITE except when included in Schedule 3.
AMYLOCAINE.
# ANABOLIC STEROIDAL AGENTS.
ANAGRELIDE.
ANAKINRA.
ANASTROZOLE.
ANCESTIM.
ANCROD and its immunoglobulin antidote.
ANDEXANET ALFA.
ANECORTAVE.
# ANDROGENIC STEROIDAL AGENTS.
# ANDROISOXAZOLE.
# ANDROSTANOLONE.
# ANDROSTENEDIOL.
# ANDROSTENEDIONE.
ANGIOTENSIN AMIDE.
ANIDULAFUNGIN.
ANIMAL BLOOD PRODUCTS for veterinary use including:
 (a) whole blood;
 (b) blood components, including red cells, white cells, platelets, and plasma (including cryoprecipitate); and
 (c) the following plasma-derived therapeutic proteins, and their equivalent recombinant alternatives:
  (i) albumin;
  (ii) anticoagulation complex;
  (iii) C1 esterase inhibitors;
  (iv) clotting factors;
  (v) fibrinogen;
  (vi) protein C;
  (vii) prothrombin complex concentrate (PCC);
  (viii) thrombin;
  (ix) haemoglobin.
ANIRACETAM.
ANISTREPLASE.
ANTAZOLINE except when included in Schedule 2.
ANTIBIOTIC SUBSTANCES except:
 (a) when separately specified in these Schedules; or
 (b) nisin.
ANTIGENS for human therapeutic use except when separately specified in this Schedule.
ANTIHISTAMINES except:
 (a) when included in Schedule 2 or 3; or
 (b) when separately specified in this Schedule.
ANTIMONY for therapeutic use except when separately specified in these Schedules.
ANTISERA (immunosera) for human use by injection except when separately specified in these Schedules.
# AOD‑9604 (CAS No. 221231‑10‑3).
APALUTAMIDE.
APIXABAN.
APOCYNUM spp.
APOMORPHINE.
APRACLONIDINE.
APRAMYCIN.
APREMILAST.
APREPITANT.
APROTININ.
ARBUTIN (BETA) in oral preparations except herbal preparations containing 500 mg or less beta‑arbutin per recommended daily dose.
ARECOLINE.
ARIPIPRAZOLE.
ARMODAFINIL.
ARSENIC for human therapeutic use except when separately specified in these Schedules.
ARTEMETHER.
ARTICAINE.
ASCIMINIB.
ASENAPINE.
ASFOTASE ALFA.
ASPARAGINASE.
ASPIRIN when:
 (a) combined with caffeine, paracetamol or salicylamide; or
 (b) combined with any derivative of the substances mentioned in paragraph (a); or
 (c) for injection.
ASTEMIZOLE.
ASUNAPREVIR.
# ATAMESTANE.
ATAZANAVIR.
ATENOLOL.
ATEZOLIZUMAB.
ATIPAMEZOLE.
ATOMOXETINE.
ATORVASTATIN.
ATOSIBAN.
ATOVAQUONE.
ATRACURIUM BESILATE.
ATROPA BELLADONNA (belladonna) except when included in Schedule 2.
ATROPINE except when included in Schedule 2.
ATROPINE METHONITRATE.
AURANOFIN.
AUROTHIOMALATE SODIUM.
AVACOPAN.
AVATROMBOPAG.
AVELUMAB.
AVILAMYCIN except:
 (a) in animal feed premixes containing 15% or less of avilamycin activity; or
 (b) in animal feeds containing 50 mg/kg or less of avilamycin activity.
AVIPTADIL.
AXITINIB.
AVOPARCIN.
AZACITIDINE.
AZACYCLONOL.
AZAPERONE.
AZAPROPAZONE.
AZARIBINE.
AZATADINE except when included in Schedule 3.
AZATHIOPRINE.
AZELAIC ACID for therapeutic use except when included in Schedule 2.
AZELASTINE except when included in Schedule 2.
AZITHROMYCIN.
AZLOCILLIN.
AZTREONAM.
BACAMPICILLIN.
BACITRACIN.
BACLOFEN.
BALOXAVIR MARBOXIL.
BALSALAZIDE.
BAMBERMYCIN (flavophospholipol) except:
 (a) when included in Schedule 6; or
 (b) in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances.
BAMBUTEROL.
BAMETHAN.
BAMIPINE.
BARBITURATES except when separately specified in these Schedules.
BARICITINIB.
BASILIXIMAB.
BAZEDOXIFENE.
BECAPLERMIN.
BECLAMIDE.
BECLOMETASONE except when included in Schedule 2.
BELATACEPT.
BELIMUMAB.
BELUMOSUDIL.
BELZUTIFAN.
BEMEGRIDE.
BENACTYZINE.